What is Hyperion DeFi's market cap?

Hyperion DeFi (HYPD) has a market capitalization of $52.7M and trades on NASDAQ.

Who are Hyperion DeFi's competitors?

Hyperion DeFi's key competitors include MicroStrategy Incorporated, Hyperliquid Strategies Inc Common Stock, Bit Digital, Inc. Ordinary Shares, and others. These companies compete in similar markets and product categories.

Who does Hyperion DeFi partner with?

Hyperion DeFi's notable partners include Kinetiq Research Pte. Ltd., Pier Two Pty Ltd, Anchorage Digital Bank, and others.

Where is Hyperion DeFi headquartered?

Hyperion DeFi is headquartered in United States of America and employs approximately 57 people. It has been publicly traded since 2018.

Hyperion DeFi (HYPD) Stock Fundamentals & Financials

Market cap

$52.68M+34.1%

Earnings

Q2 2026 report

August 12, 2026

Revenue$357.7KMiss by $909.0K EPS$0.92Miss by $1.32

Read the full report

Next report

Nov 12, 2026 (in 2 months)

Revenue estimate$1.9M

EPS estimate-$0.33

Competitors

By market cap

MicroStrategy$48.9B-49.5%

PUR

Hyperliquid Strategies Inc.$2.3B—

HRO

Harrow$1.5B+2.7%

Schering-Plough$891.1M—

Bit Digital$562.6M-36.1%

Outlook Therapeutics, Inc.$151.3M+43.4%

Hyperion DeFi$52.7M+34.1%

ENDRA Life Sciences Inc.$8.2M+164%

By revenue growth

By net margin

PUR

Hyperliquid Strategies Inc.3,229.83%—

HRO

Harrow-19.75%+4.4pp

Bit Digital-237.19%-184pp

MicroStrategy-1,624.27%-466pp

Profile

Hyperion DeFi, Inc. is a dual-strategy enterprise that manages a strategic digital asset treasury focused on the Hyperliquid ecosystem while continuing the development of proprietary ophthalmic medical technology. The company provides public market investors with exposure to the Hyperliquid blockchain through native token accumulation, validator operations, and decentralized finance (DeFi) yield strategies. Simultaneously, it is finalizing the registration and potential monetization of its Optejet liquid drug delivery device for chronic eye diseases.

Competitive position

Hyperion DeFi is the first U.S. publicly listed company to build a strategic treasury specifically around the Hyperliquid ecosystem. It maintains a unique position by bridging traditional public equity markets with high-frequency decentralized finance infrastructure.

GeographiesUnited States, Global

Customer segmentsInstitutional, DeFi Protocols, Healthcare Providers

Business modelAsset Management, Staking-as-a-Service, Licensing, Product Development

SuppliersHyperliquid Layer-1 Blockchain, Digital asset custodians, Hardware wallet providers, Cloud infrastructure for validator nodes

CustomersDeFi protocol users, Institutional liquidity seekers, Ophthalmic drug manufacturers, Clinical research organizations

CountryUnited States of America

Listed2018

Employees57.0

CEOHyunsu Jung

SectorHealthcare

IndustryMedical - Devices

Websitehyperiondefi.com

FilingsSEC EDGAR

FAQ

What is Hyperion DeFi's market cap?: Hyperion DeFi (HYPD) has a market capitalization of $52.7M and trades on NASDAQ.
Who are Hyperion DeFi's competitors?: Hyperion DeFi's key competitors include MicroStrategy Incorporated, Hyperliquid Strategies Inc Common Stock, Bit Digital, Inc. Ordinary Shares, and others. These companies compete in similar markets and product categories.
Who does Hyperion DeFi partner with?: Hyperion DeFi's notable partners include Kinetiq Research Pte. Ltd., Pier Two Pty Ltd, Anchorage Digital Bank, and others.
Where is Hyperion DeFi headquartered?: Hyperion DeFi is headquartered in United States of America and employs approximately 57 people. It has been publicly traded since 2018.